Evidence map›Paper›PMID 11139617›Full record

ArticleNucleic acids research2001

Conserved stem-loop structures in the HIV-1 RNA region containing the A3 3' splice site and its cis-regulatory element: possible involvement in RNA splicing.

S Jacquenet, D Ropers, P S Bilodeau, L Damier, A Mougin, C M Stoltzfus, C Branlant

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in Nucleic acids research, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 79 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Production of HIV-1Frontiers in microbiology · 2017
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

S JacquenetLaboratoire de Maturation des ARN et Enzymologie Moléculaire, UMR 7567 UHP-CNRS, France.
D Ropers
P S Bilodeau
L Damier
A Mougin
C M Stoltzfus
C Branlant
Centre National de la Recherche Scientifique · FR

Funding

REGULATION OF HIV-1 RNA SPLICINGR01AI036073 · NIAID · UNIVERSITY OF IOWA · PI AMENDT, BRAD · 1995 to 2010
$2.5M
Regulation of HIV-1 RNA SplicingR56AI036073 · NIAID · UNIVERSITY OF IOWA · PI STOLTZFUS, CONRAD · 2005 to 2005
$332k
NIAID NIH HHS R01 AI036073NIAID NIH HHS R56 AI036073
6 · The paper itself

Abstract

The HIV-1 transcript is alternatively spliced to over 30 different mRNAs. Whether RNA secondary structure can influence HIV-1 RNA alternative splicing has not previously been examined. Here we have determined the secondary structure of the HIV-1/BRU RNA segment, containing the alternative A3, A4a, A4b, A4c and A5 3' splice sites. Site A3, required for tat mRNA production, is contained in the terminal loop of a stem-loop structure (SLS2), which is highly conserved in HIV-1 and related SIVcpz strains. The exon splicing silencer (ESS2) acting on site A3 is located in a long irregular stem-loop structure (SLS3). Two SLS3 domains were protected by nuclear components under splicing condition assays. One contains the A4c branch points and a putative SR protein binding site. The other one is adjacent to ESS2. Unexpectedly, only the 3' A residue of ESS2 was protected. The suboptimal A3 polypyrimidine tract (PPT) is base paired. Using site-directed mutagenesis and transfection of a mini-HIV-1 cDNA into HeLa cells, we found that, in a wild-type PPT context, a mutation of the A3 downstream sequence that reinforced SLS2 stability decreased site A3 utilization. This was not the case with an optimized PPT. Hence, sequence and secondary structure of the PPT may cooperate in limiting site A3 utilization.

Indexed as

3' Untranslated RegionsConserved SequenceNucleic Acid ConformationRegulatory Sequences, Nucleic AcidRNA Splice SitesAlternative SplicingBase SequenceGene Products, tatHeLa CellsHIV-1HumansMolecular Sequence DataMutagenesis, Site-DirectedRNA, Viraltat Gene Products, Human Immunodeficiency VirusTumor Cells, Cultured3' Untranslated RegionsGene Products, tatRNA Splice SitesRNA, Viraltat Gene Products, Human Immunodeficiency Virus

Identifiers

PMID11139617
PMCPMC29680
OpenAlexW2111032921

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.